Headlines

Expert Outlook: AbbVie Through The Eyes Of 10 Analysts

Latest Ratings for ABBV

Date Firm Action From To
Feb 2022 UBS Downgrades Buy Neutral
Feb 2022 Mizuho Maintains Buy
Feb 2022 Barclays Maintains Equal-Weight

View More Analyst Ratings for ABBV

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *